A Prospective Evaluation of Predictive Risk Factors, Severity of Liver Injury and Course of Anti –Tubercular Treatment Induced Hepatotoxicity
Journal Title: National Journal of Medical Research - Year 2018, Vol 8, Issue 1
Abstract
"Background: Hepatotoxicity is an established complication of Anti-tubercular treatment. However, there is limited information on the incidence, possible predictive risk factors and course of anti- tubercular treat-ment induced hepatotoxicity. Objective: The study was planned to evaluate incidence, possible predictive risk factors and course of anti-tubercular treatment induced hepatotoxicity (ATTIH ) . Methodology: The present prospective study was conducted with Newly diagnosed pulmonary and extra-pulmonary tuberculosis patients admitted from may 2014 to may 2016.A sample size of 150 patients were put on ATT ranging from 6 months to 12 months depending on type of Tuberculosis. Their pretreatment clinical, biochemical and radiological parameters were recorded. These parameters were compared between cases and controls by appropriate statistical methods. Patients with abnormal base line LFT’S, Treatment defaulters, failure, MDR cases and patients with NASH, cirrhosis ,acute viral hepatitis &/or renal or cardiac disease were excluded from this study. Results: Out of 150 patients 22 patients (14.7%) developed ATTIH. Among 22 patients 15 (68.2%) were females and 7 (31.8%) were males. Higher incidence of ATTIH was seen in patients with low BMI of 18.99kg/m2(45.16%), pretreatment low serum albumin <2.5gm( 65.21%), Corrected calcium < 7.9gm/dl( 58.8%), Serum cholesterol < 200mg/dl (59.1%), Extra pulmonary TB(69.3%), concomitant paracetamol in-take(77.7%). Age and consanguinity were statistically insignificant. In this study 18 patients (81.81%) devel-oped ATTIH within 2 weeks of starting ATT with average of 9 days and severity of liver injury ranged from mild with ALT ( 51-250IU/L) in 12(54.5%), intermediate (251-500IU/L) in 7 ( 31.8%) and severe (ALT >500IU/L) in 3(13.6%). Normalization of LFTs after ATTIH was seen within first 2 weeks in 11(50%) patients with average of 11 days. ATTIH was associated with prolongation of expected treatment duration in 16 (72.7%) patients. Recurrence of ATTIH was not seen in any patient on reintroduction of treatment. Among 22 patients, 19(86.36%) were cured, 2(9.1%) expired and 1 patient lost follow up. Conclusion: Early identification of predictive risk factors, modification of treatment with close monitoring and hospitalization are required for reducing morbidity, mortality and treatment completion in ATTIH. "
Authors and Affiliations
Waseem Javid, Majid Abbas Khawaja, Ghulam Nabi Dhobi
Keywords
Related Articles
- EP ID EP602526
- DOI -
- Views 107
- Downloads 0
Pulmonary Functions in Adolescents with Sickle Cell Anaemia: A Case Control Study
Introduction: Sickle cell diseases are one the commonest hemoglobinopathies in the central and southern India. About 20-30% deaths in Sickle cell anaemia (SCA) patients occur due to respiratory disorder. Studies had show...
Profile of Acute Epididymo-Orchitis Patients in Arifin Achmad Regional General Hospital Riau Province, Indonesia
"Purpose: To evaluate the profile of acute epididymo-orchitis patients. Materials and Methods: We reviewed medical records of acute epididymo-orchitis patients underwent management in urology ward of Arifin Achmad Regio...
Magnitude and Determinants of Noncompliance for Screening and Management of Diabetic Retinopathy
"Introduction: Strategies to reduce visual disabilities due to diabetic retinopathy (DR) include early detection and prompt management. Patient compliance is a crucial a factor to achieve this goal. The aim of the study...
Study of Audiovisual Reaction Time in Indian Classical Singers
Introduction: Audiovisual Reaction Time involves the time period taken for the response to auditory or visual stimuli which depends on the intactness of the sensory and the motor system. Objective: The present study was...
A Prospective Evaluation of Predictive Risk Factors, Severity of Liver Injury and Course of Anti –Tubercular Treatment Induced Hepatotoxicity
"Background: Hepatotoxicity is an established complication of Anti-tubercular treatment. However, there is limited information on the incidence, possible predictive risk factors and course of anti- tubercular treat-ment...